|
|
|
|
| LEADER |
02575nam a22002895i 4500 |
| 001 |
978-1-59259-142-8 |
| 005 |
20191026171240.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2001 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781592591428
|
| 024 |
7 |
|
|a 10.1385/1592591426
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Parkinson's Disease
|b Methods and Protocols /
|c edited by M. Maral Mouradian.
|
| 250 |
|
|
|a 1st ed. 2001.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2001.
|
| 300 |
|
|
|a XI, 317 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Medicine,
|v 62
|
| 505 |
0 |
|
|a Genetics -- Point Mutations in the ?-Synuclein Gene -- Autosomal Recessive Juvenile Parkinsonism (AR-JP): Genetic Diagnosis -- Molecular Pathogenetic Studies -- Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy as ?-Synucleinopathies -- ?-Synuclein/Amyloid Interactions -- Functional Defect Conferred by the Parkinson's Disease-Causing ?-Synuclein (Ala30Pro) Mutation -- Molecular Biology of Dopamine-Induced Apoptosis -- Animal Models of Induced Apoptotic Death in the Substantia Nigra -- Apoptotic Morphology in Phenotypically Defined Dopaminergic Neurons of the Substantia Nigra -- The Role of Nitric Oxide in Parkinson's Disease -- Oxidative Stress Indices in Parkinson's Disease -- Molecular Aspects of Basal Ganglia Function -- Quantification of Tyrosine Hydroxylase mRNA -- Immunochemical Analysis of Dopamine Transporters in Parkinson's Disease -- Dopamine Transporter and Vesicular Monoamine Transporter Knockout Mice -- Transcription Mechanisms for Dopamine Receptor Genes -- Detection of DNA/Protein Interactions in Dopamine Receptor Genes -- In Situ Hybridization on Brain Tissue -- Regulation of Striatal N-Methyl-D-Aspartate Receptor (NMDAR) Function by Phosphorylation of its Subunits in Parkinsonian Rats -- Molecular Therapies -- Chronic Intracerebral Delivery of Trophic Factors via a Programmable Pump as a Treatment for Parkinsonism -- Grafting Genetically Engineered Cells into the Striatum of Nonhuman Primates -- Encapsulated Cell Implants as a Novel Treatment for Parkinson's Disease -- Neural Stem Cell Technology as a Novel Treatment for Parkinson's Disease.
|
| 650 |
|
0 |
|a Neurology .
|
| 650 |
1 |
4 |
|a Neurology.
|
| 700 |
1 |
|
|a Mouradian, M. Maral.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1385/1592591426
|